230 related articles for article (PubMed ID: 22445618)
1. Long-term follow-up of vanishing tumors in the brain: how should a lesion mimicking primary CNS lymphoma be managed?
Okita Y; Narita Y; Miyakita Y; Ohno M; Fukushima S; Maeshima A; Kayama T; Shibui S
Clin Neurol Neurosurg; 2012 Nov; 114(9):1217-21. PubMed ID: 22445618
[TBL] [Abstract][Full Text] [Related]
2. [Germ-cell tumors of the central nervous system in childhood: retrospective study of 13 patients].
Voirin J; Klein O; Chastagner P; Moret C; Vignaud JM; Auque J; Marchal JC
Neurochirurgie; 2008 Apr; 54(2):55-62. PubMed ID: 18355878
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
Agarwal PA; Menon S; Smruti BK; Singhal BS
Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
[TBL] [Abstract][Full Text] [Related]
4. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
5. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
[TBL] [Abstract][Full Text] [Related]
6. [Clinical problems in the treatment of primary central nervous system malignant lymphoma].
Keyaki A; Nabeshima S; Hashimoto S; Waga S
No To Shinkei; 2000 Sep; 52(9):781-7. PubMed ID: 11064864
[TBL] [Abstract][Full Text] [Related]
7. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract][Full Text] [Related]
8. Clinical Reasoning: Vanishing tumor: A 7-year puzzle solved.
Kelly CM; O'Dowd S; Drake C; McCarthy L; Bermingham N; Fanning N; O'Sullivan SS; O'Reilly S
Neurology; 2015 Sep; 85(9):e69-73. PubMed ID: 26324866
[No Abstract] [Full Text] [Related]
9. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
10. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
[TBL] [Abstract][Full Text] [Related]
11. [Imaging diagnosis of central nervous system malignant lymphoma].
Kan S
Brain Nerve; 2014 Aug; 66(8):917-26. PubMed ID: 25082314
[TBL] [Abstract][Full Text] [Related]
12. [Characteristic imaging features of primary central nervous system lymphoma in comparison with pathological findings].
Liu HY; Zhang XL; Chen YP; Qiu SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):333-6. PubMed ID: 19246316
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective analysis of 8 cases with primary central nervous system lymphoma].
Zhou XQ; Liu XQ; Kong JC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):455-7. PubMed ID: 12905861
[TBL] [Abstract][Full Text] [Related]
14. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Küker W; Nägele T; Thiel E; Weller M; Herrlinger U
Neurology; 2005 Oct; 65(7):1129-31. PubMed ID: 16217075
[TBL] [Abstract][Full Text] [Related]
16. [T-type primary lymphoma of the central nervous system in immunocompetent patients].
Barrena-Caballo MR; Blanch-Labrador M; Giménez-Mas JA; Alberdi-Viñas J; Pascual-Piazuelo M; Zubiri-Ara L
Rev Neurol; 2003 Jan 16-31; 36(2):125-30. PubMed ID: 12589598
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
[TBL] [Abstract][Full Text] [Related]
18. Immature teratomas of the central nervous system: is adjuvant therapy mandatory?
Phi JH; Kim SK; Park SH; Hong SH; Wang KC; Cho BK
J Neurosurg; 2005 Dec; 103(6 Suppl):524-30. PubMed ID: 16383251
[TBL] [Abstract][Full Text] [Related]
19. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
[TBL] [Abstract][Full Text] [Related]
20. Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Turatti M; Gajofatto A; Bianchi MR; Ferrari S; Monaco S; Benedetti MD
J Neurol Sci; 2013 Jan; 324(1-2):156-62. PubMed ID: 23151425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]